Dr Glendon Gale Cox, MD, MBA, MHSA | |
3901 Rainbow Blvd, Kansas City, KS 66160-0001 | |
(913) 588-7201 | |
Not Available |
Full Name | Dr Glendon Gale Cox |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 3901 Rainbow Blvd, Kansas City, Kansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205872934 | NPI | - | NPPES |
300068152 | Other | RAILROAD MEDICARE | |
100119790C | Medicaid | KS | |
10799059 | Other | MO | BCBS KANSAS CITY |
201976123 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 0419321 (Kansas) | Primary |
Entity Name | Kansas University Physicians, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Scientific evidence reporting on the use of cannabis for the treatment of chronic pain or post-traumatic stress syndrome (PTSD) is too limited to conclude its safety or efficacy, say researchers from the US Department of Veterans Affairs (VA).
Results from clinical trials conducted in Tanzania show that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection. Findings from the trials, which were conducted by investigators from Dartmouth Medical School in the United States, will be published in the next issue of AIDS, the leading journal in the field of HIV and AIDS research. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
The COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) has reviewed reports of rare cases of blood clots with low platelets following vaccination with the AstraZeneca COVID-19 vaccine (including Covishield) since their onset a few weeks ago.
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6-9, by Kerin Adelson, M.D., assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale-New Haven.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Glendon Gale Cox, MD, MBA, MHSA Po Box 411851, Kansas City, MO 64141-1851 Ph: (913) 588-6805 | Dr Glendon Gale Cox, MD, MBA, MHSA 3901 Rainbow Blvd, Kansas City, KS 66160-0001 Ph: (913) 588-7201 |
News Archive
Scientific evidence reporting on the use of cannabis for the treatment of chronic pain or post-traumatic stress syndrome (PTSD) is too limited to conclude its safety or efficacy, say researchers from the US Department of Veterans Affairs (VA).
Results from clinical trials conducted in Tanzania show that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection. Findings from the trials, which were conducted by investigators from Dartmouth Medical School in the United States, will be published in the next issue of AIDS, the leading journal in the field of HIV and AIDS research. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
The COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) has reviewed reports of rare cases of blood clots with low platelets following vaccination with the AstraZeneca COVID-19 vaccine (including Covishield) since their onset a few weeks ago.
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6-9, by Kerin Adelson, M.D., assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale-New Haven.
› Verified 1 days ago
Dr. Benjamin Adam Schatz, MD Radiology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 4032, Kansas City, KS 66160 Phone: 405-416-0500 | |
Pauline R Sleder, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6805 | |
Dr. Steven Mclain Lemons, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 4032, Kansas City, KS 66160 Phone: 913-588-6805 | |
Philip L Johnson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Mail Stop 4032, Kansas City, KS 66160 Phone: 913-588-6800 Fax: 913-588-7899 | |
Dr. Ernest John Madarang, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Department Of Radiology, Kansas City, KS 66103 Phone: 913-588-6875 | |
Norman L Martin, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Mail Stop 4032, Kansas City, KS 66160 Phone: 913-588-6800 Fax: 913-588-7899 | |
Irfanullah Haider, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 4032, Kansas City, KS 66160 Phone: 913-588-5000 |